Related Experiment Video
Updated: Jan 29, 2026
08:24
A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
Published on: November 25, 2022
2.7K
Yeast-Based Screens to Target Alpha-Synuclein Toxicity
Inês Caldeira Brás1, Blagovesta Popova2,3, Gerhard H Braus2,3
1Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, University Medical Center Goettingen, Goettingen, Germany.
Methods in Molecular Biology (Clifton, N.J.)
|February 17, 2019
Summary
Budding yeast (Saccharomyces cerevisiae) screens identify genetic modifiers of alpha-synuclein toxicity. This accelerates the discovery of therapeutic targets for Parkinson's disease (PD) and related synucleinopathies.
Area of Science:
- Cell Biology
- Genetics
- Neuroscience
Background:
- The budding yeast Saccharomyces cerevisiae (S. cerevisiae) is a powerful model organism due to conserved biological processes with higher eukaryotes.
- Yeast genetics and high-throughput screens have been instrumental in understanding disease mechanisms, particularly those involving protein misfolding.
- Alpha-synuclein (aSyn) accumulation is central to Parkinson's disease (PD) and other synucleinopathies.
Purpose of the Study:
- To describe a yeast screen protocol for identifying genetic modifiers of alpha-synuclein (aSyn) toxicity.
- To leverage yeast genetics for discovering novel therapeutic targets for synucleinopathies.
- To accelerate research into the molecular mechanisms underlying Parkinson's disease.
Main Methods:
- Utilized Saccharomyces cerevisiae as an experimental model system.
- Developed and implemented a high-throughput genetic screen.
- Focused on identifying genetic factors that modify alpha-synuclein (aSyn) toxicity.
Main Results:
- The described yeast screen protocol effectively identifies genetic modifiers of aSyn toxicity.
- This approach facilitates the discovery of novel molecular targets with therapeutic potential.
- The study provides a foundation for further investigation into synucleinopathies.
Conclusions:
- Yeast screens are a valuable tool for dissecting complex disease mechanisms like those in Parkinson's disease.
- The identified genetic modifiers can inform the development of new therapeutic strategies for synucleinopathies.
- This protocol accelerates the identification of potential interventions for neurodegenerative diseases.
Related Concept Videos
01:28Yeast Signaling
17.2K
Yeasts are single-celled organisms, but unlike bacteria, they are eukaryotes (cells with a nucleus). Cell signaling in yeast is similar to signaling in other eukaryotic cells. A ligand, such as a protein or a small molecule released from a yeast cell, attaches to a receptor on the cell surface. The binding stimulates second-messenger kinases to activate or inactivate transcription factors that further regulate gene expression. Many of the yeast intracellular signaling cascades have similar...
17.2K
01:26Toxic Reactions: Overview
1.9K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.9K
02:46Genetic Screens
5.7K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.7K
02:57Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
01:26Targets for Drug Action: Overview
10.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.2K
01:22Target Cell Response to Hormones
5.7K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.7K